Loyal
Signal active
Organization
Contact Information
Overview
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia. By quantifying and regulating the processes of aging, the company aims to slow the emergence and mitigate the intensity of age-related ailments, thereby facilitating extended periods of improved health for both species.
About
Industries
Biotechnology, Pet, Veterinary
Founded
2019
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Loyal headquartered in United States, North America, operates in the Biotechnology, Pet, Veterinary sector. The company focuses on Biotechnology and has secured $8.3B in funding across 72 round(s). With a team of 101-250 employees, Loyal is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Loyal, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
6
Investors
1
Lead Investors
0
Total Funding Amount
$115.0M
Details
4
Loyal has raised a total of $115.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 27.0M | ||
| 2020 | Seed | 11.0M | ||
| 2022 | Early Stage Venture | 20.0M | ||
| 2024 | Early Stage Venture | 45.0M |
Investors
Loyal is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Loyal | - | FUNDING ROUND - Loyal | 45.0M |
| BoxGroup | - | FUNDING ROUND - BoxGroup | 45.0M |
| Loyal | - | FUNDING ROUND - Loyal | 12.0M |
| Bridge Bank | - | FUNDING ROUND - Bridge Bank | 12.0M |
Recent Activity
There is no recent news or activity for this profile.